The futures market is pointing to another jump today following a reasonable night for shares on Wall Street.
Here’s a quick recap:
- FTSE 100 (UK): up 0.4%
- DAX (Germany): down 0.13%
- CAC 40 (France): down 0.13%
- Dow Jones (USA): up 0.36%
- NASDAQ (USA): up 0.4%
Protection solutions business Ansell Limited (ASX: ANN) has agreed to sell its Sexual Wellness business for a grand sum of US$600 million, while also announcing a share buy-back program for up to 10% of the company’s issued capital.
Aristocrat Leisure Limited (ASX: ALL) is one of a number of companies that have reported financial results today. It reported a 21.6% increase in revenue during the first-half to $1.23 billion, while its profit surged nearly 57% to around $250 million.
Mesoblast limited (ASX: MSB) also released its third-quarter results this morning. The company reported further cash outflow improvements with a reduction of $16.4 million for the nine months, compared to the prior corresponding period.
Likewise, the Gentrack Group Ltd (ASX: GTK) share price will be in focus after it reported a 24% increase in revenue for the first half of 2017, in addition to 46% growth in net profit. It noted that its employee headcount had risen 24% over the same period last year.
Investors will also be hopeful for some stability in the resources sector following yesterday’s sell-down. The Fortescue Metals Group Limited (ASX: FMG) share price was among those hit, down almost 5%, while gold miners St Barbara Ltd (ASX: SBM) and Regis Resources Limited (ASX: RRL) also fell sharply.
Before getting started on your day, be sure to check out these two articles:
- Probably, my top 2 small cap share ideas right now
- 4 healthcare shares I want to buy for long-term growth
FREE REPORT! Click here to discover the Motley Fool’s #1 ASX dividend recommendation – currently paying a 7.9% gross yield!
Even better, this ‘under the radar’ consumer play is growing like gangbusters. Shares have rocketed 100% in the last 5 years, DOUBLING shareholders’ investment. So what’s not to like?
Simply click here to grab your free copy of this up-to-the-minute research report right now.
Motley Fool contributor Ryan Newman has no position in any stocks mentioned. The Motley Fool Australia has no position in any of the stocks mentioned. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.